Endpoints News· @endpts · X·· 8 小时前AI 评分42
AI 导读
nChroma停止了其唯一的临床试验,并裁减了约一半员工,这是基因药物初创企业的最新挫折。https://endpoints.news/nchroma-bio-stops-its-only-clinical-study-early-lays-off-50/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
nChroma halted its only clinical trial and laid off about half its staff, the latest setback for genetic medicine startups. https://endpoints.news/nchroma-bio-stops-its-only-clinical-study-early-lays-off-50/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com